Retreatment and prolonged therapy with subcutaneous bortezomib in patients with relapsed multiple myeloma: A randomized, controlled, phase III study-Reference-Cited by-同舟云学术

Retreatment and prolonged therapy with subcutaneous bortezomib in patients with relapsed multiple myeloma: A randomized, controlled, phase III study

Author:

Terpos Evangelos¹^ORCID,Gobbi Marco²,Potamianou Anna³,Lahaye Marjolein⁴,Couturier Catherine⁵,Cavo Michele⁶

Affiliation:

1. Department of Clinical Therapeutics; School of Medicine; University of Athens; Athens Greece

2. Clinical Hematology; IRCCS AOU San Martino-IST; Genova Italy

3. EMEA Medical Affairs; Janssen-Cilag; Neuss Germany

4. Biometrics; Janssen-Cilag; Tilburg Netherlands

5. EMEA Medical Affairs; Janssen-Cilag; Issy-les-Moulineaux Cedex France

6. Seràgnoli Institute of Hematology; University of Bologna; Bologna Italy

Funder

Janssen Global Services, LLC

Millennium Pharmaceuticals, Inc

Publisher

Wiley

Subject

Hematology,General Medicine

Link

Reference37 articles.

5. Multiple myeloma, version 1.2013;Anderson;J Natl Compr Canc Netw,2013

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献